SEC Form 4 · accession 0002124509-26-000010
Revolution Medicines, Inc. · RVMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Mancini
Officer — See Remarks
Period of report
Sep 18, 2026
Accepted (ET)
Sep 22, 2026 · 6:00 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001628171
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 18, 2026 | S | 1,764 | $196.94 | D | 40,352 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
Remarks
Chief Global Commercialization Officer